Clinical trial · Interventional
Facilitators and Barriers to Cancer Treatment Among Texas Residents
NCT07105046CI-TRIAL-00104349not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
This trial uses semi-structured interviews and focus groups to determine facilitators and barriers of receiving timely cancer treatment among multiple cancers, across multiple insurance types, throughout Texas
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Focus Groups | Other | — | UNRESOLVED |
| Interviews | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Semi-structured Interview
- description
- Participants will be recruited through the Texas Cancer Registry (TCR).
- interventionNames
- Other: Focus Groups
- type
- EXPERIMENTAL
- label
- Online Focus Group
- description
- Participants will be recruited through the Texas Cancer Registry (TCR).
- interventionNames
- Other: Interviews
Primary outcomes (1)
- measure
- 1. Safety and Adverse Events (AEs)
- timeFrame
- Through study completion; an average of 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Aims 1 and 2 In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Verbal consent will be obtained * Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study * Males and females; Age ≥ 18 years old * Documented diagnosis of breast, colorectal, lung, and prostate cancer patients, stage I-IV * Either English or Spanish-speaking Exclusion Criteria: Aims 1 and 2 An individual who meets any of the following criteria will be excluded from participation in this study: * Patients who are cognitively impaired * Pregnant women
References
Publications (0)
Data not yet available
No reference posted for this study.